Apple hires another high-profile cardiologist

Apple has hired another big name in cardiology, signaling that it’s getting serious about its heart health initiatives, CNBC first reported Oct. 30.

CNBC reported that David Tsay, a professor of cardiology and associate chief transformation officer at Columbia University Medical Center, joined Apple’s team after the physician updated his LinkedIn profile this week. Apple has declined to comment on the hire.

Tsay is the second big-league cardiologist to join the team following the recruitment of Alexis Beatty, a physician who’d previously worked at the University of Washington. Apple has been dialed in on heart health for years now—its latest-generation smartwatch boasts ECG capabilities—and Tsay’s hire suggests the company might be trying to improve its relationship with the medical world.

Technology that facilitates the management of heart disease is a big moneymaker, especially considering the fact that CVD remains the leading cause of death in the U.S. Jeffrey Wessler, a New York cardiologist, told CNBC that CV tech is the “holy grail of disease management.”

“Cardiovascular disease has been such a huge and difficult problem to tackle,” he said to the outlet. “But we finally have consumer-grade tech catching up that offer a new set of solutions.”

Read the full story below:

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.